Product Images Duloxicaine

This is a description of a pharmaceutical product manufactured by W Pharma. It includes a Duloxetine Capsule of 30mg (30 count) and Lidocaine HCL Cream (96.4 grams). It also provides the National Drug Code (NDC) 72835-802-02 and mentions that it is RX Only. The enclosed inserts should be referred to for complete prescribing information. It must be stored at a temperature of 20-25°C (68 to 77°F) and USP Controlled Room Temperature should be maintained. It is important to keep this medication away from children.*

The chart shows the proportion of patients who experienced a relapse over time after being randomized to receive either a placebo or duloxetine for treatment. The x-axis represents the number of days it took for patients to experience a relapse, while the y-axis shows the percentage of patients who relapsed. The higher the curve on the line, the greater the number of relapses. The study used the Kaplan-Meier estimator method to analyze and demonstrate the results.*

This is a graph that shows the proportion of patients with relapse over time from randomization to relapse, comparing the outcomes of a placebo treatment versus Duloxetine. The x-axis represents the time in days, while the y-axis shows the percentage of patients who experienced a relapse. The graph was created using the Kaplan-Meier estimator method.*

This text presents a chart showing the percentage of patients who experienced improvement with different doses of duloxetine and placebo. The effectiveness was measured by the percentage improvement in pain from the baseline. There is not enough information to determine what the acronym "W w m = W [ S R ™" means.*

The text is describing a chart or graph that compares the percentage of patients who have improved in regards to pain levels from a baseline measurement. This comparison is made between three different treatments: Duloxsine 60 mo BID, Duloxetine 60 mg QD, and Placebo. The data is presented using percentages, with the variable "R" being used to represent the percent improvement in pain from baseline for each treatment.*

The text describes a chart that displays the percentage of patients who experienced improvement in pain with the use of Duloxetine (60 mg, twice daily or once daily) compared to a Placebo. The chart shows different levels of improvement (ranging from 0% to 100%) on the horizontal axis and the percentage of patients who experienced that level of improvement on the vertical axis.*

This is a graph showing the percentage of patients who improved while taking Duloxetine at 120mg twice daily, Duloxetine at 60mg once daily, and a placebo. The horizontal axis shows the percentage of improvement in pain from baseline, while the vertical axis shows the number of patients.*

This is a graph that shows the percentage of patients who experienced improvement in pain from baseline after taking Duloxetine 60/120 mg once daily compared to placebo. The graph ranges from 0-100% improvement and shows various percentage points on the y-axis and different levels of percent improvement on pain from the baseline on the x-axis.*

The text provides data regarding the percentage of patients improved by Duloxetine 60mg compared to a placebo. The chart shows that at a once-daily dosage, 100% of patients improved with Duloxetine while the placebo had 0% improvement. Additionally, the text shows a chart displaying percent improvement in pain from baseline, which includes numerical values up to 100%.*